Listen
Newsletter Sign Up
For You
Latest
AI
US Midterms 2026
Brazil Election 2026
World
Politics
Health
Crime & justice
Science & technology
Social issues
Sports
Money
Entertainment
Environment/energy
Military
Culture
Weather
Media
Home
Bias Split
Sources
Controversies
Sign Up for Our Free Newsletters
Sign Up for Our Free Newsletters
Sign Up!
Sign Up Now!
About
Contact Us
Newsletter Archive
Media
FAQ
Glossary
Verity Ed
Privacy Policy
© 2026 Improve the News Foundation. All rights reserved.
Version 7.18.2
© 2026 Improve the News Foundation.
All rights reserved.
Version 7.18.2
Diseases & conditions
Infectious diseases
COVID-19
Malaria
Hepatitis
Dengue
Influenza
HIV
Ebola
Zika
Medicine & healthcare
Idaho State Lawmakers Propose Ban on mRNA Vaccines
+2
FEB 2023
FEB 2023
North Korea
North Korea Tests More Missiles, Warns Of Turning Pacific Into 'Firing Range'
+7
FEB 2023
FEB 2023
Politics
Report: Trudeau's Use of Emergency Powers was Justified
+3
FEB 2023
FEB 2023
Medicine & healthcare
Study: Protection From Past COVID Infection Can Last 10 Months
+3
FEB 2023
FEB 2023
Economic conditions & trends
Report: Energy Costs Could Drive 141M to Extreme Poverty
+4
FEB 2023
FEB 2023
United States of America
Moderna CEO to Testify on COVID Vaccine Price Hike
+2
FEB 2023
FEB 2023
China
China: Retirees Protest Plan to Cut Health Benefits
+5
FEB 2023
FEB 2023
COVID-19
House GOP Launches Probe into COVID Origins
+3
FEB 2023
FEB 2023
Show More
Sports
Djokovic to be Granted Visa for Australian Open
+5
NOV 2022
NOV 2022
Medicine & healthcare
Opioid Settlement: Walmart Agrees To $3.1B Framework
+7
NOV 2022
NOV 2022
Diseases & conditions
Moderna: Omicron Booster Effective Against New Subvariants
+1
NOV 2022
NOV 2022
China
Australia Might Ask China to Lift Trade Restrictions
+5
NOV 2022
NOV 2022
Diseases & conditions
Study: COVID Reinfections May Increase Risk of Serious Disease, Death
+3
NOV 2022
NOV 2022
Ukraine
Putin To Skip G20 summit
+9
NOV 2022
NOV 2022
China
Study: Chances of Finding COVID Ancestor 'Almost Nil'
+1
NOV 2022
NOV 2022
Diseases & conditions
Study: Paxlovid May Reduce Long COVID Risk
NOV 2022
NOV 2022
Show More
/cloudfront-us-east-2.images.arcpublishing.com/reuters/MVXCLS6ZL5KLBKS3JCZHS6I24U.jpg)
